Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

FromThe Lancet Oncology in conversation with


David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

FromThe Lancet Oncology in conversation with

ratings:
Length:
5 minutes
Released:
Jun 30, 2022
Format:
Podcast episode

Description

David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.Read the full article:Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in EuropeContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Jun 30, 2022
Format:
Podcast episode

Titles in the series (100)

Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.